2-(4-Methylpiperidin-1-yl)-5-(trifluoromethyl)aniline, 5g

4-Chloro-2-(trifluoromethyl)pyrimidine, 98.0%, 250mg

5-((BENZYLOXY)CARBONYL)-5-AZASPIRO[2.3]HEXANE-1-CARBOXYLIC ACID, 95.0%, 500mg

3-(Methylamino)propionitrile>98.0%(GC)(T)25mL

N-4-Phenylasparagine, 95.0%, 5g

([Ir(dF(CF3ppy)2)(5,5'-CF3-bpy)]PF6, 99.0%, 100mg

6-Hydroxy-nicotinic acid methyl ester, 97.0%, 1g

2-(2H-Benzotriazol-2-yl)-6-(1-methyl-1-phenylethyl)-4-(1,1,3,3-tetramethylbutyl)phenol, 98%, 500g

N,N-Diethyl-1,4-phenylenediamine>98.0%(GC)(T)500g

4-(4-Hydroxyphenyl)-4-oxobutanoic acid, 97%, 100mg

1,3-Dihydro-1-(1,2,3,6-tetrahydro-4-pyridinyl)-2H-benzimidazole-2-one, 95.0%, 5g

4-(DIMETHYLAMINO)-4-PHENYLCYCLOHEXAN-1-ONE, 95.0%, 500mg

Ácido úrico, mínimo 99 %, para bioquímica, 250 g, envase de vidrio